Acifran, with the CAS number 72420-38-3, is a chemical compound primarily recognized for its application in the field of pharmaceuticals. It is classified as a non-steroidal anti-inflammatory drug (NSAID) and is known for its analgesic and anti-inflammatory properties. Acifran functions by inhibiting the cyclooxygenase (COX) enzymes, which play a crucial role in the synthesis of prostaglandins, compounds that mediate inflammation and pain. The substance typically appears as a white to off-white crystalline powder and is soluble in organic solvents. Its pharmacological profile suggests that it may be effective in treating conditions such as arthritis and other inflammatory disorders. However, like many NSAIDs, Acifran may be associated with side effects, including gastrointestinal issues and potential cardiovascular risks, necessitating careful consideration of its use in clinical settings. As with any pharmaceutical compound, it is essential to adhere to regulatory guidelines and conduct thorough research to ensure safety and efficacy.

Acifran

72420-38-3: (+-)-4,5-Dihydro-5-methyl-4-oxo-5-phenyl-2-furoic acid, (R,S)-4,5-Dihydro-5-methyl-4-oxo-5-phenyl-2-furancarbonsaeure, 2-Furancarboxylic acid, 4,5-dihydro-5-methyl-4-oxo-5-phenyl-, (+-)-, 4,5-Dihydro-5-methyl-4-oxo-5-phenyl-2-furancarboxylic acid, 5-Methyl-4-Oxo-5-Phenyl-4,5-Dihydrofuran-2-Carboxylic Acid, Acifran [USAN:INN], Acifranum, Acifranum [INN-Latin], Ay 25712, Reductol, Unii-B1X701S0Mv, (±)-Acifran, Acifran

ACIFRAN

Acifran (AY 25712) is an HM74A/GPR109A and GPR109B agonist and displays antihyperlipidemic activity.

CAS 72420-38-3: Acifran

Acifran

Ref: 54-BUP03636

ACIFRAN

Ref: IN-DA00FB6D

Acifran

Ref: TM-T22547